Literature DB >> 24881163

The mistreatment of major depressive disorder.

Joel Paris.   

Abstract

OBJECTIVE: To examine the effects of classification on treatment in major depressive disorder (MDD).
METHOD: This is a narrative review.
RESULTS: MDD is a highly heterogeneous category, leading to problems in classification and in specificity of treatment. Current models classify all depressions within a single category. However, the construct of MDD obscures important differences between severe disorders that require pharmacotherapy, and mild-to-moderate disorders that can respond to psychotherapy or remit spontaneously. Patients with mild-to-moderate MDD are being treated with routine or overly aggressive pharmacotherapy.
CONCLUSIONS: The current classification fails to address the heterogeneity of depression, leading to mistreatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24881163      PMCID: PMC4079242          DOI: 10.1177/070674371405900306

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  35 in total

1.  Causal relationship between stressful life events and the onset of major depression.

Authors:  K S Kendler; L M Karkowski; C A Prescott
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

2.  Selling sickness: the pharmaceutical industry and disease mongering.

Authors:  Ray Moynihan; Iona Heath; David Henry
Journal:  BMJ       Date:  2002-04-13

3.  Is there a delay in the antidepressant effect? A meta-analysis.

Authors:  Michael A Posternak; Mark Zimmerman
Journal:  J Clin Psychiatry       Date:  2005-02       Impact factor: 4.384

4.  Keeping our eyes on STAR*D.

Authors:  Marcia Valenstein
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

Review 5.  Major depression prevalence is very high, but the syndrome is a poor proxy for community populations' clinical treatment needs.

Authors:  Scott B Patten
Journal:  Can J Psychiatry       Date:  2008-07       Impact factor: 4.356

Review 6.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

Review 7.  Definition and epidemiology of treatment-resistant depression.

Authors:  M Fava; K G Davidson
Journal:  Psychiatr Clin North Am       Date:  1996-06

8.  Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.

Authors:  Raymond W Lam; Sidney H Kennedy; Sophie Grigoriadis; Roger S McIntyre; Roumen Milev; Rajamannar Ramasubbu; Sagar V Parikh; Scott B Patten; Arun V Ravindran
Journal:  J Affect Disord       Date:  2009-08-11       Impact factor: 4.839

9.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

10.  The importance and limits of harm in identifying mental disorder.

Authors:  Jerome C Wakefield; Michael B First
Journal:  Can J Psychiatry       Date:  2013-11       Impact factor: 4.356

View more
  6 in total

1.  Hippocampal subfield-specific connectivity findings in major depressive disorder: A 7 Tesla diffusion MRI study.

Authors:  John W Rutland; Stephanie Brown; Gaurav Verma; Rebecca E Feldman; Himanshu Sharma; Matthew Markowitz; Molly Schneider; Bradley N Delman; James Murrough; Priti Balchandani
Journal:  J Psychiatr Res       Date:  2019-02-18       Impact factor: 4.791

2.  Socioeconomic status, alcohol use disorders, and depression: A population-based study.

Authors:  Aurélie M Lasserre; Sameer Imtiaz; Michael Roerecke; Markus Heilig; Charlotte Probst; Jürgen Rehm
Journal:  J Affect Disord       Date:  2022-01-02       Impact factor: 4.839

3.  Temperament, personality, and treatment outcome in major depression: a 6-month preliminary prospective study.

Authors:  Yuka Kudo; Atsuo Nakagawa; Taisei Wake; Natsumi Ishikawa; Chika Kurata; Mizuki Nakahara; Teruo Nojima; Masaru Mimura
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-19       Impact factor: 2.570

4.  Rational antidepressant use.

Authors:  Daniel Dunleavy
Journal:  BJPsych Bull       Date:  2018-06

5.  Treatment-Resistant Depression in Portugal: Perspective From Psychiatry Experts.

Authors:  João M Bessa; Serafim Carvalho; Inês B Cunha; Milene Fernandes; Ana Matos-Pires; Rui Neves; Albino J Oliveira-Maia; Susana Santos; Vítor Santos
Journal:  Front Psychiatry       Date:  2022-03-30       Impact factor: 4.157

Review 6.  A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?

Authors:  Gerwyn Morris; Michael Berk; Basant K Puri
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.